PT Metro Healthcare Indonesia Tbk (ISX:CARE) EBIT : Rp-1,199 Mil (TTM As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is PT Metro Healthcare Indonesia Tbk EBIT?

PT Metro Healthcare Indonesia Tbk's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2024 was Rp9,010 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2024 was Rp-1,199 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. PT Metro Healthcare Indonesia Tbk's annualized ROC % for the quarter that ended in Dec. 2024 was -0.64%. PT Metro Healthcare Indonesia Tbk's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 1.04%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. PT Metro Healthcare Indonesia Tbk's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -0.02%.

PT Metro Healthcare Indonesia Tbk EBIT Historical Data

The historical data trend for PT Metro Healthcare Indonesia Tbk's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Metro Healthcare Indonesia Tbk EBIT Chart

PT Metro Healthcare Indonesia Tbk Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT

Get a 7-Day Free Trial

25,098.80

31,938.52

-3,982.93

-30,347.75

-1,198.72

PT Metro Healthcare Indonesia Tbk Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EBIT	Get a 7-Day Free Trial															-3,689.80	-2,387.40	-5,072.44	-2,748.99	9,010.10

Competitive Comparison of PT Metro Healthcare Indonesia Tbk's EBIT

For the Medical Care Facilities subindustry, PT Metro Healthcare Indonesia Tbk's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Metro Healthcare Indonesia Tbk's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PT Metro Healthcare Indonesia Tbk's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where PT Metro Healthcare Indonesia Tbk's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

PT Metro Healthcare Indonesia Tbk EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp-1,199 Mil.

PT Metro Healthcare Indonesia Tbk (ISX:CARE) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

PT Metro Healthcare Indonesia Tbk's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

	ROC % (Q: Dec. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2024 )	+	Invested Capital (Q: Dec. 2024 ))	/ count )
=	-23092.916 * ( 1 - -19.4% )	/	( (4290437.194	+	4318192.8)	/ 2 )
=	-27572.941704	/	4304314.997
=	-0.64 %

where

	Invested Capital		(Q: Sep. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	4014238.193	-	36896.086	-	( 513127.06	-	max(0, 872135.259	-	559040.172	+	513127.06	))
=	4290437.194

	Invested Capital		(Q: Dec. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	4021105.412	-	33653.104	-	( 492069.664	-	max(0, 874056.732	-	543316.24	+	492069.664	))
=	4318192.8

Note: The Operating Income data used here is four times the quarterly (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

PT Metro Healthcare Indonesia Tbk's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2024		Q: Dec. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	36040.408	/	( ( (3446385.274 + max(-9593.596, 0))	+	(3474696.898 + max(-803.36699999996, 0)) )	/	2 )
=	36040.408	/	( ( 3446385.274	+	3474696.898 )	/	2 )
=	36040.408	/	3460541.086
=	1.04 %

where Working Capital is:

	Working Capital		(Q: Sep. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(34924.923	+	4520.336	+	5869.598)	-	(36896.086	+	0	+	18012.367)
=	-9593.596

	Working Capital		(Q: Dec. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(39287.1	+	6268.092	+	5466.722)	-	(33653.104	+	0	+	18172.177)
=	-803.36699999996

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

PT Metro Healthcare Indonesia Tbk's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2024 )
	=	-1198.721	/	7460644.175
	=	-0.02 %

PT Metro Healthcare Indonesia Tbk EBIT Related Terms

Thank you for viewing the detailed overview of PT Metro Healthcare Indonesia Tbk's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Metro Healthcare Indonesia Tbk Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PT Metro Healthcare Indonesia Tbk (ISX:CARE) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Raya Serang Km 16,8, RT / RW 005/001, Kel. Sukamulya, Kec. Cikupa, Tangerang, IDN, 15710

Website

https://www.metrohealthcareindonesia.co.id

PT Metro Healthcare Indonesia Tbk provides integrated health services that consist of hospital and technology-based health services and training centers to produce professionals in health services. The company manages hospitals that are members of the Metro Hospital Group. Its business segment comprises Inpatient and Outpatient. The majority of revenue is derived from the inpatient segment.